Recorded: May 5, 2021
Recent technological advances offer tremendous possibility to shift the detection of Alzheimer’s disease and other dementias to its early stages. This webinar provides an overview of novel technologies and emerging biomarkers for early disease detection. The panelists also address issues around the value of early detection and practical considerations from the clinical perspective and health policy perspective.
Moderators: Paige Lin, Antia Goh
Panelists: Michelle M Mielke, Gill Livingston, Darius Lakdawalla